Jaguar Health, Inc. financial data

Symbol
JAGX on Nasdaq
Location
San Francisco, CA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 14 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 106% % -46%
Quick Ratio 37% % -29%
Return On Equity -40% % -231%
Return On Assets -3.6% % -158%
Operating Margin -279% %

Shares

Label TTM Value / Value Unit Change %
Entity Public Float $28,000,000 USD 183%
Weighted Average Number of Shares Outstanding, Basic 1,513,178 shares 304%
Weighted Average Number of Shares Outstanding, Diluted 1,513,178 shares 304%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $11,785,000 USD -0.8%
Cost of Revenue $2,131,000 USD 2.2%
Research and Development Expense $15,187,000 USD -1.8%
Selling and Marketing Expense $9,672,000 USD 49%
General and Administrative Expense $17,618,000 USD 8.2%
Costs and Expenses $44,608,000 USD 9.6%
Operating Income (Loss) $32,823,000 USD -8.6%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $41,038,000 USD -7.1%
Income Tax Expense (Benefit) $0 USD
Net Income (Loss) Attributable to Parent $1,840,250 USD -152%
Earnings Per Share, Basic -47 USD/shares 98%
Earnings Per Share, Diluted -47 USD/shares 98%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $3,527,000 USD -73%
Accounts Receivable, after Allowance for Credit Loss, Current $1,437,000 USD 15%
Inventory, Net $10,628,000 USD 9.9%
Assets, Current $29,402,000 USD -20%
Property, Plant and Equipment, Net $483,000 USD 1.5%
Operating Lease, Right-of-Use Asset $1,062,000 USD 0.47%
Intangible Assets, Net (Excluding Goodwill) $17,285,000 USD -8.8%
Assets $49,472,000 USD -15%
Accounts Payable, Current $8,443,000 USD 85%
Accrued Liabilities, Current $4,175,000 USD 27%
Contract with Customer, Liability, Current $170,000 USD 0%
Liabilities, Current $36,122,000 USD 82%
Contract with Customer, Liability, Noncurrent $425,000 USD -29%
Operating Lease, Liability, Noncurrent $918,000 USD 22%
Liabilities $45,113,000 USD 5.2%
Accumulated Other Comprehensive Income (Loss), Net of Tax $839,000 USD -22%
Retained Earnings (Accumulated Deficit) $376,855,000 USD -12%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $4,359,000 USD -67%
Liabilities and Equity $49,472,000 USD -15%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $7,316,000 USD -3.8%
Net Cash Provided by (Used in) Financing Activities $4,966,000 USD -60%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $2,314,000 USD -144%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $3,527,000 USD -73%
Interest Paid, Excluding Capitalized Interest, Operating Activities $6,000 USD -33%
Deferred Tax Assets, Valuation Allowance $93,567,000 USD 66%
Deferred Tax Assets, Gross $94,112,000 USD 63%
Operating Lease, Liability $1,144,000 USD 2%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $40,444,000 USD -7.5%
Lessee, Operating Lease, Liability, to be Paid $1,945,000 USD 8.7%
Property, Plant and Equipment, Gross $1,033,000 USD 5.7%
Operating Lease, Liability, Current $226,000 USD -39%
Lessee, Operating Lease, Liability, to be Paid, Year Two $376,000 USD 61%
Lessee, Operating Lease, Liability, to be Paid, Year One $367,000 USD 17%
Operating Lease, Weighted Average Discount Rate, Percent 0.24 pure 20%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $801,000 USD 20%
Lessee, Operating Lease, Liability, to be Paid, Year Three $388,000 USD 63%
Deferred Tax Assets, Operating Loss Carryforwards $77,749,000 USD 50%
Preferred Stock, Shares Issued 1,332 shares 1245%
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Unrecognized Tax Benefits $77,000 USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four $365,000 USD 49%
Operating Lease, Payments $63,000 USD -81%
Preferred Stock, Shares Outstanding 1,332 shares 1245%
Amortization of Intangible Assets $1,918,000 USD -0.05%
Depreciation, Depletion and Amortization $479,000 USD -4.4%
Deferred Tax Assets, Net of Valuation Allowance $545,000 USD -61%
Share-based Payment Arrangement, Expense $1,082,000 USD -42%
Interest Expense $175,000 USD -130%